In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Danaher takes over Beckman Coulter in deal worth $6.8bn

Executive Summary

In its latest deal that adds more instrumentation offerings, Danaher Corp. (testing and analytical systems, dental technologies, and diagnostics) is acquiring public biomedical testing company Beckman Coulter Inc. for $83.50 per share (a 47% premium to the ten-day average prior to December 9, 2010, when the takeover was rumored). Including Beckman’s 70.9mm shares outstanding, plus the assumption of debt and net cash, the transaction is valued at $6.8bn.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies